The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Nivolumab (anti-PD-1; BMS-936558, ONO-4538) in combination with platinum-based doublet chemotherapy (PT-DC) in advanced non-small cell lung cancer (NSCLC).
Scott Joseph Antonia
Consultant or Advisory Role - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb
Research Funding - MedImmune
Julie R. Brahmer
Consultant or Advisory Role - Bristol-Myers Squibb (U)
Stock Ownership - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Scott N. Gettinger
Consultant or Advisory Role - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Laura Quan Man Chow
Consultant or Advisory Role - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb; University of Washington
Rosalyn A. Juergens
Research Funding - Bristol-Myers Squibb
Frances A. Shepherd
Consultant or Advisory Role - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb
Scott Andrew Laurie
Research Funding - Bristol-Myers Squibb
David E. Gerber
No relevant relationships to disclose
Jonathan Wade Goldman
Research Funding - Bristol-Myers Squibb; Genentech
Yun Shen
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb (B)
Christopher Harbison
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Suresh Alaparthy
Employment or Leadership Position - Bristol-Myers Squibb
Allen C. Chen
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Hossein Borghaei
Consultant or Advisory Role - Bristol-Myers Squibb; Genentech
Honoraria - Bristol-Myers Squibb; Genentech
Research Funding - Arisaph Pharmaceuticals; Millennium; Pfizer
Naiyer A. Rizvi
Consultant or Advisory Role - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb; MedImmune; Roche/Genentech
Research Funding - Arisaph Pharmaceuticals; Millennium; Pfizer